Oliver Darlington

Alderton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Carer Health-Related Quality of Life: A Review of Modelling Considerations in National Institute for Health and Care Excellence Technology Appraisals (2000-2023).

Carer Health-Related Quality of Life: A Review of Modelling Considerations in National Institute for Health and Care Excellence Technology Appraisals (2000-2023).

Journal: PharmacoEconomics - open

Published: March 31, 2025

Indirect Comparison of Maralixibat and Odevixibat for the Treatment of Progressive Familial Intrahepatic Cholestasis.

Indirect Comparison of Maralixibat and Odevixibat for the Treatment of Progressive Familial Intrahepatic Cholestasis.

Journal: Clinical therapeutics

Published: February 28, 2025

Understanding health inequalities in Wales using the Blinder-Oaxaca decomposition method.

Understanding health inequalities in Wales using the Blinder-Oaxaca decomposition method.

Journal: Frontiers in public health

Published: September 29, 2022

Cost of health inequality to the NHS in Wales.

Cost of health inequality to the NHS in Wales.

Journal: Frontiers in public health

Published: June 01, 2022

Toward an economy of wellbeing: The economic impact of the Welsh healthcare sector.

Toward an economy of wellbeing: The economic impact of the Welsh healthcare sector.

Journal: Frontiers in public health

Published: May 26, 2022

The public health impact of loneliness during the COVID-19 pandemic.

The public health impact of loneliness during the COVID-19 pandemic.

Journal: BMC public health

Published: April 04, 2022

Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease: A Health-Economic Analysis of DAPA-CKD.

Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease: A Health-Economic Analysis of DAPA-CKD.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: March 30, 2022

Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial.

Cost-effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: October 08, 2021

Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan.

Estimating the Economic and Clinical Value of Reducing Antimicrobial Resistance to Three Gram-negative Pathogens in Japan.

Journal: Journal of health economics and outcomes research

Published: August 04, 2021

Cost Effectiveness of Screening for Hepatitis C Virus in Iraq in the Era of Simplified Testing and Treatment.

Cost Effectiveness of Screening for Hepatitis C Virus in Iraq in the Era of Simplified Testing and Treatment.

Journal: PharmacoEconomics

Published: June 28, 2021

Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review.

Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review.

Journal: Advances in therapy

Published: November 13, 2020

Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HF.

Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis of DAPA-HF.

Journal: European journal of heart failure

Published: May 28, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026